Dynepo - treatment of anaemia

Dynepo (epoetin delta), indicated for the treatment of anaemia associated with chronic renal failure in patients on dialysis and non-dialysed patients, has been launched by Shire Pharmaceuticals.

Further information: Shire 01256 894000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more